当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析

科伦药业

(002422)

  

流通市值:413.80亿  总市值:506.42亿
流通股本:13.09亿   总股本:16.02亿

科伦药业(002422)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润29.21亿元,每股收益1.57元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2623144.28万元,未分配利润1133763.51万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产3839236.40万元,负债1216092.12万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入16,788,775,17311,827,102,2576,219,417,41321,453,929,237
营业总成本13,414,966,7519,235,465,6744,767,842,90218,277,363,122
营业利润3,809,979,4912,911,941,8501,632,448,2043,654,143,158
利润总额3,705,661,9632,865,067,3851,624,795,1723,580,426,050
净利润2,921,005,5772,215,778,8881,285,801,4132,646,639,362
其他综合收益-17,620,21420,299,128-845,212-60,842,218
综合收益总额2,903,385,3632,236,078,0161,284,956,2012,585,797,144
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计19,065,882,89718,930,129,68119,208,487,06718,290,026,502
非流动资产合计19,326,481,07819,110,939,86918,467,971,29818,164,874,638
资产总计38,392,363,97538,041,069,55037,676,458,36536,454,901,140
流动负债合计10,142,720,7309,633,452,6599,692,236,6009,993,110,193
非流动负债合计2,018,200,4732,476,141,5632,111,769,4373,446,197,381
负债合计12,160,921,20312,109,594,22211,804,006,03713,439,307,574
归属于母公司股东权益合计22,555,029,73122,306,532,24922,260,402,45219,672,377,989
股东权益合计26,231,442,77225,931,475,32825,872,452,32823,015,593,566
负债和股东权益合计38,392,363,97538,041,069,55037,676,458,36536,454,901,140
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计19,166,712,48513,110,809,2596,561,069,02627,053,848,794
经营活动现金流出小计15,891,287,90510,578,110,0285,282,305,91021,716,779,863
经营活动产生的现金流量净额3,275,424,5802,532,699,2311,278,763,1165,337,068,931
投资活动现金流入小计9,555,768,1104,181,586,2051,772,849,0226,027,299,996
投资活动现金流出小计10,945,429,5004,341,758,6191,102,215,2139,397,624,986
投资活动产生的现金流量净额-1,389,661,390-160,172,414670,633,809-3,370,324,990
筹资活动现金流入小计4,860,746,5133,589,028,7381,204,294,6836,676,527,247
筹资活动现金流出小计6,229,432,6084,472,324,0811,512,332,6058,735,292,935
筹资活动产生的现金流量净额-1,368,686,095-883,295,343-308,037,922-2,058,765,688
汇率变动对现金及现金等价物的影响-10,344,335-1,529,0831,810,6065,194,000
现金及现金等价物净增加额506,732,7601,487,702,3911,643,169,609-86,827,747
期末现金及现金等价物余额5,095,056,9076,076,026,5386,231,493,7564,588,324,147
最新报告期:2024-11-04
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中信建投袁清慧,贺菊颖1.862.102.312024-11-04
国盛证券宋歌,张金洋,胡偌碧1.832.022.392024-11-04
东海证券杜永宏1.822.152.512024-10-31
中信证券陈竹1.872.132.472024-10-31
华泰证券代雯,沈卢庆1.812.082.562024-10-29
TOP↑